Literature DB >> 34499618

Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation.

Young-June Jin1, Ramesh Chennupati1, Rui Li1, Guozheng Liang1, ShengPeng Wang1,2, András Iring1,3, Johannes Graumann4, Nina Wettschureck1,5,6,7, Stefan Offermanns1,5,6,7.   

Abstract

Formation of NO by endothelial NOS (eNOS) is a central process in the homeostatic regulation of vascular functions including blood pressure regulation, and fluid shear stress exerted by the flowing blood is a main stimulus of eNOS activity. Previous work has identified several mechanosensing and -transducing processes in endothelial cells, which mediate this process and induce the stimulation of eNOS activity through phosphorylation of the enzyme via various kinases including AKT. How the initial mechanosensing and signaling processes are linked to eNOS phosphorylation is unclear. In human endothelial cells, we demonstrated that protein kinase N2 (PKN2), which is activated by flow through the mechanosensitive cation channel Piezo1 and Gq/G11-mediated signaling, as well as by Ca2+ and phosphoinositide-dependent protein kinase 1 (PDK1), plays a pivotal role in this process. Active PKN2 promoted the phosphorylation of human eNOS at serine 1177 and at a newly identified site, serine 1179. These phosphorylation events additively led to increased eNOS activity. PKN2-mediated eNOS phosphorylation at serine 1177 involved the phosphorylation of AKT synergistically with mTORC2-mediated AKT phosphorylation, whereas active PKN2 directly phosphorylated human eNOS at serine 1179. Mice with induced endothelium-specific deficiency of PKN2 showed strongly reduced flow-induced vasodilation and developed arterial hypertension accompanied by reduced eNOS activation. These results uncover a central mechanism that couples upstream mechanosignaling processes in endothelial cells to the regulation of eNOS-mediated NO formation, vascular tone, and blood pressure.

Entities:  

Keywords:  Cell Biology; Endothelial cells; Hypertension; Nitric oxide; Vascular Biology

Mesh:

Substances:

Year:  2021        PMID: 34499618      PMCID: PMC8553558          DOI: 10.1172/JCI145734

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  72 in total

1.  Phosphatidylinositol 3-kinase gamma mediates shear stress-dependent activation of JNK in endothelial cells.

Authors:  Y M Go; H Park; M C Maland; V M Darley-Usmar; B Stoyanov; R Wetzker; H Jo
Journal:  Am J Physiol       Date:  1998-11

2.  Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo.

Authors:  Z Luo; Y Fujio; Y Kureishi; R D Rudic; G Daumerie; D Fulton; W C Sessa; K Walsh
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

4.  Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation.

Authors:  T J McCabe; D Fulton; L J Roman; W C Sessa
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

5.  Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635.

Authors:  Belinda J Michell; M Brennan Harris; Zhi-Ping Chen; Hong Ju; Virginia J Venema; Michele A Blackstone; Wei Huang; Richard C Venema; Bruce E Kemp
Journal:  J Biol Chem       Date:  2002-08-08       Impact factor: 5.157

Review 6.  Vascular nitric oxide: Beyond eNOS.

Authors:  Yingzi Zhao; Paul M Vanhoutte; Susan W S Leung
Journal:  J Pharmacol Sci       Date:  2015-09-28       Impact factor: 3.337

7.  Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size.

Authors:  Qian Li; Dmitriy Atochin; Satoshi Kashiwagi; John Earle; Annie Wang; Emiri Mandeville; Kazuhide Hayakawa; Livius V d'Uscio; Eng H Lo; Zvonimir Katusic; William Sessa; Paul L Huang
Journal:  Stroke       Date:  2013-08-29       Impact factor: 7.914

Review 8.  Endothelial NOS: perspective and recent developments.

Authors:  Victor Garcia; William C Sessa
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

Review 9.  Akt signalling in health and disease.

Authors:  Ingeborg Hers; Emma E Vincent; Jeremy M Tavaré
Journal:  Cell Signal       Date:  2011-05-17       Impact factor: 4.315

10.  PKN2 and Cdo interact to activate AKT and promote myoblast differentiation.

Authors:  Sang-Jin Lee; Jeongmi Hwang; Hyeon-Ju Jeong; Miran Yoo; Ga-Yeon Go; Jae-Rin Lee; Young-Eun Leem; Jong Woo Park; Dong-Wan Seo; Yong Kee Kim; Myong-Joon Hahn; Jeung-Whan Han; Jong-Sun Kang; Gyu-Un Bae
Journal:  Cell Death Dis       Date:  2016-10-20       Impact factor: 8.469

View more
  4 in total

Review 1.  The Effects of Acidosis on eNOS in the Systemic Vasculature: A Focus on Early Postnatal Ontogenesis.

Authors:  Dina K Gaynullina; Olga S Tarasova; Anastasia A Shvetsova; Anna A Borzykh; Rudolf Schubert
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

2.  Protein kinase N2 connects blood flow with NO production in a double AKT.

Authors:  David Jr Fulton; David W Stepp
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

Review 3.  Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation.

Authors:  Maarten M Brandt; Caroline Cheng; Daphne Merkus; Dirk J Duncker; Oana Sorop
Journal:  Front Physiol       Date:  2021-12-23       Impact factor: 4.566

4.  Piezo1 Channel Activation Reverses Pulmonary Artery Vasoconstriction in an Early Rat Model of Pulmonary Hypertension: The Role of Ca2+ Influx and Akt-eNOS Pathway.

Authors:  Thais Porto Ribeiro; Solène Barbeau; Isabelle Baudrimont; Pierre Vacher; Véronique Freund-Michel; Guillaume Cardouat; Patrick Berger; Christelle Guibert; Thomas Ducret; Jean-François Quignard
Journal:  Cells       Date:  2022-07-30       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.